Categories Articles FDA Panel Narrowly Backs a First-of-a-Kind COVID-19 Antiviral Pill Made By Merck Post author By crystalg Post date November 30, 2021 TIME Tags Antiviral, Backs, COVID19, FirstofaKind, Made, Merck, Narrowly, panel, Pill ← Genetic study of ancient teeth debunks theory that Native Americans originated in Japan → Microsoft is selling ugly Windows sweaters again, and this time, it’s Minesweeper